Pancreaticoduodenectomy (Whipple Resections) in Patients Without Malignancy: Are They All `Chronic Pancreatitis'?

Pancreaticoduodenectomy (Whipple resection) has evolved into a safe procedure in major high-volume medical centers for the treatment of pancreatic adenocarcinoma and refractory chronic pancreatitis. However, some Whipple resections performed for a clinical suspicion of malignancy reveal only benign disease on pathologic examination. We evaluated the frequency of such Whipple resections without tumor in a large series of pancreaticoduodenectomies and classified the diverse pancreatic and biliary tract diseases present in these specimens. Of 442 Whipple resections performed during 1999–2001, 47 (10.6%) were negative for neoplastic disease and, in 40 cases, had been performed for a clinical suspicion of malignancy. Most Whipple resections revealed benign pancreatic disease, including 8 (17%) alcohol-associated chronic pancreatitis, 4 (8.5%) gallstone-associated pancreatitis, 1 (2.1%) pancreas divisum, 6 (12.8%) “ordinary” chronic pancreatitis of unknown etiology, and 11 (23.4%) lymphoplasmacytic sclerosing pancreatitis. In particular, patients with lymphoplasmacytic sclerosing pancreatitis were all thought to harbor malignancy, whereas only 13 of 19 (68.4%) of Whipple resections showing histologically “ordinary” forms of chronic pancreatitis were performed for a clinical suspicion of malignancy. Benign biliary tract disease, including three cases of primary sclerosing cholangitis, two cases of choledocholithiasis-associated chronic biliary tract disease, and four fibroinflammatory strictures isolated to the intrapancreatic common bile duct, was a common etiology for clinically suspicious Whipple resections (22.5% of cases). Pancreatic intraepithelial neoplasia (PanIN) was a common finding among all pancreata, whether involved by pancreatitis or histologically normal. Overall, PanIN 1A/1B was present in 68.1%, PanIN 2 in 40.4%, and PanIN 3 in just 2.1%. These findings indicate that “benign but clinically suspicious” Whipple resections are relatively common in high-volume centers (9.2%) and reveal a diverse group of clinicopathologically distinctive pancreatic and biliary tract disease.

[1]  R. Wiesner,et al.  Primary sclerosing cholangitis: findings on cholangiography and pancreatography. , 1983, Radiology.

[2]  T. Nikaido,et al.  High serum IgG4 concentrations in patients with sclerosing pancreatitis. , 2001, The New England journal of medicine.

[3]  D. Gouma,et al.  Incidence and clinical findings of benign, inflammatory disease in patients resected for presumed pancreatic head cancer. , 1997, Gastrointestinal endoscopy.

[4]  R H Hruban,et al.  Pancreatic Intraepithelial Neoplasia: A New Nomenclature and Classification System for Pancreatic Duct Lesions , 2001, The American journal of surgical pathology.

[5]  O. Peters,et al.  Jaundice caused by a pancreatic mass: an exceptional presentation of Crohn's disease. , 2001, Journal of clinical gastroenterology.

[6]  A. Servais,et al.  Autoimmune pancreatitis mimicking cancer of the head of pancreas: report of two cases. , 2001, Acta gastro-enterologica Belgica.

[7]  G. Klöppel,et al.  Ductal lesions in patients with chronic pancreatitis show K‐ras mutations in a frequency similar to that in the normal pancreas and lack nuclear immunoreactivity for p53 , 2000, Cancer.

[8]  K. Shiratori,et al.  Chronic pancreatitis caused by an autoimmune abnormality , 1995, Digestive Diseases and Sciences.

[9]  T. Chiba,et al.  Autoimmune-related pancreatitis is associated with autoantibodies and a Th1/Th2-type cellular immune response. , 2000, Gastroenterology.

[10]  J. Sahel,et al.  Eosinophilic pancreatitis: report of a case. , 1990, Pancreas.

[11]  R. Kozarek,et al.  Presentation and treatment of annular pancreas in an adult population. , 1995, The American journal of gastroenterology.

[12]  D. Whitcomb,et al.  Chronic pancreatitis: diagnosis, classification, and new genetic developments. , 2001, Gastroenterology.

[13]  M. Stolte,et al.  Non-alcoholic duct destructive chronic pancreatitis , 1997, Gut.

[14]  K. Asagoe,et al.  CASE REPORT: Autoimmune Pancreatitis Detected as a Mass in the Head of the Pancreas with Contiguous Fibrosis Around the Superior Mesenteric Artery , 2004, Digestive Diseases and Sciences.

[15]  R. Scully,et al.  Atypical Forms of Microglandular Hyperplasia of the Cervix Simulating Carcinoma: A Report of Five Cases and Review of the Literature , 1989, The American journal of surgical pathology.

[16]  T. Moojen,et al.  Differential diagnosis of focal pancreatitis and pancreatic cancer. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

[17]  J. Hébert,et al.  The characteristic appearance of non-alcoholic duct destructive chronic pancreatitis: a report of 2 cases. , 2000, Archives of pathology & laboratory medicine.

[18]  M. Okubo,et al.  Corticosteroid-responsive diabetes mellitus associated with autoimmune pancreatitis , 2000, The Lancet.

[19]  M. Talamini,et al.  Pancreaticoduodenectomy for benign disease. , 1996, American journal of surgery.

[20]  H. Sakai,et al.  Autoimmune Pancreatitis as a New Clinical Entity (Three Cases of Autoimmune Pancreatitis with Effective Steroid Therapy) , 1997, Digestive Diseases and Sciences.

[21]  K. Azuma,et al.  Autoimmune pancreatitis detected as a mass in the tail of the pancreas , 2000, Journal of gastroenterology and hepatology.

[22]  K. Okazaki,et al.  Multiple Pancreatic Masses Associated With Autoimmunity , 1998, American Journal of Gastroenterology.

[23]  T. Chiba,et al.  Clinical analysis of autoimmune-related pancreatitis. , 2000 .

[24]  M. Farnell,et al.  The Mayo clinic approach to the surgical treatment of adenocarcinoma of the pancreas. , 2001, The Surgical clinics of North America.

[25]  T. Chiba,et al.  Recent concept of autoimmune-related pancreatitis , 2001, Journal of Gastroenterology.

[26]  Chronic pancreatitis and inflammatory bowel disease: true or coincidental association? , 1999 .

[27]  G. Erkelens,et al.  Sclerosing pancreato-cholangitis responsive to steroid therapy , 1999, The Lancet.

[28]  K. Lillemoe,et al.  Resected adenocarcinoma of the pancreas— 616 patients: Results, outcomes, and prognostic indicators , 2000, Journal of Gastrointestinal Surgery.

[29]  W. Frankel,et al.  Major pancreatic resections for chronic pancreatitis. , 2001, Archives of pathology & laboratory medicine.

[30]  C. Johnson,et al.  Tuberculosis of the pancreas. , 1995, Postgraduate medical journal.

[31]  Kenji Kawaguchi,et al.  Lymphoplasmacytic sclerosing pancreatitis with cholangitis: a variant of primary sclerosing cholangitis extensively involving pancreas. , 1991, Human pathology.

[32]  K. Lillemoe,et al.  Importance of hospital volume in the overall management of pancreatic cancer. , 1998, Annals of surgery.

[33]  K. Behrns,et al.  Radical pancreatoduodenectomy for misdiagnosed pancreatic mass , 1994, The British journal of surgery.

[34]  W. Frankel,et al.  Eosinophilic pancreatitis: a rare entity that can mimic a pancreatic neoplasm. , 2000, Annals of diagnostic pathology.

[35]  M. Barthet,et al.  Eosinophilic Pancreatitis Mimicking Pancreatic Neoplasia: EUS and ERCP Findings—Is Nonsurgical Diagnosis Possible? , 1998, Pancreas.

[36]  M. Schwarz,et al.  Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. , 1998, The New England journal of medicine.

[37]  Y. Oertel Guides to Clinical Aspiration Biopsy: Liver and Pancreas , 1989 .